Take Advantage Of The ‘Summer Dip’ With The FTSE 100, AstraZeneca plc & Vodafone Group plc

Now could be a great time to buy AstraZeneca plc (LON: AZN), Vodafone Group plc (LON: VOD) and the FTSE 100 (INDEXFTSE:UKX).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE100

‘Sell in May and don’t come back until St. Ledger’s day’ is a well-known saying in investing circles. Indeed, data from recent decades seems to back it up: the stock market rarely embarks on a sustained summer rally and usually falls between May and September. This has been the case in 2014, with the FTSE 100 falling by 1% over the last three months.

This means that the index is flat for the year so far, although it still appears to offer good value for money when compared to its American cousin, the S&P 500. While it trades on a price to earnings (P/E) ratio of 18.5, our FTSE 100 has a P/E of just 13.4. So, while many commentators have been getting excited about our ‘summer dip’ in terms of it being the beginning of a prolonged market correction, it could turn out to be little more than a mild, mundane and entirely predictable summer pullback.

Great Value

As a result of falls in the last few months, many top-notch FTSE 100 stocks are now even better value than they were in May. Two fine examples are AstraZeneca (LSE: AZN) and Vodafone (LSE: VOD). The former has fallen by 1.5% during the last three months, while the latter is down 7% over the same time period. This means that both companies now offer above-average yields of 4% and 5.7% respectively, which highlights their attractive valuations at current price levels.

Looking Ahead

However, there is a lot more to AstraZeneca and Vodafone that attractive prices. For example, AstraZeneca continues to make huge improvements to its drug pipeline and is gradually overcoming a sizeable patent cliff that has caused the company’s top and bottom lines to fall in recent years. Similarly, Vodafone is pursuing a sound strategy of buying undervalued assets in Europe. Although it may take many years for this strategy to come good, it looks set to put Vodafone on a long term path to strong growth and stability, which is great news for shareholders.

Certainly, the ‘summer dip’ may not yet be over. The FTSE 100, including AstraZeneca and Vodafone, may fall further. However, they seem to offer top notch value for money at present and appear to have bright futures. Indeed, with the UK economy continuing to pick up pace, and with interest rates looking less likely to move higher as a result of lower than expected inflation, a purple patch could be just around the corner. As a result, it could be worth coming back a little before St. Ledger’s day!

Peter Stephens owns shares of AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Down 31%, is this a rare chance to buy Meta stock for my ISA cheaply?

After rising to near $800 in 2025, Meta stock has pulled back to around $550. Edward Sheldon looks at whether…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

18% off its peak, is Nvidia stock now attractively priced?

Nvidia stock has given up almost a fifth of the price it commanded at its peak over the past year.…

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

The Aston Martin share price destruction helps illustrate 5 common investing mistakes!

The Aston Martin share price has been a disaster for investors. Christopher Ruane highlights a handful of lessons we can…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Dividend Shares

How this stock market correction can help boost a second income by 25%

Jon Smith explains how rising dividend yields across some existing income shares can be seen as an opportunity to grow…

Read more »

Middle-aged Caucasian woman deep in thought while looking out of the window
Investing Articles

Considering a SIPP? Today’s market could provide an excellent opportunity to start

Mark Hartley breaks down the benefits of using a SIPP for retirement, and how current market conditions could offer a…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

Looking for last-minute ISA ideas? Check out these UK stocks before April 3

Easter bank holidays mean the deadline to put cash into a Stocks and Shares ISA might be closer than UK…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

£20k in a Stocks & Shares ISA? Here’s how to target a £3,854 monthly passive income

Royston Wild explains how Stocks and Shares ISA investors can target a huge passive income -- and reveals a top…

Read more »

piggy bank, searching with binoculars
Investing Articles

Stock market correction: time to create that £1,000-a-month passive income portfolio?

Millions of Britons invest for passive income. Dr James Fox believes they should always look to do so when others…

Read more »